Darwin AG engages in the analysis of genetic materials and provides related research and development, as well as consulting services. The firm also focuses on the development, manufacture, and sale of genetically personalized products such as food supplements and cosmetics. The company was founded on March 15, 2021 and is headquartered in Munich, Germany.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company